1,971
Views
18
CrossRef citations to date
0
Altmetric
Articles

Identification and imaging of miR-155 in the early screening of lung cancer by targeted delivery of octreotide-conjugated chitosan-molecular beacon nanoparticles

ORCID Icon, , , , , , , & show all
Pages 1974-1983 | Received 12 Jun 2018, Accepted 21 Aug 2018, Published online: 09 Jan 2019

References

  • Abdolmaleki AY, Zilouei H, Khorasani SN, et al. (2018). Adsorption of tetracycline from water using glutaraldehyde-crosslinked electrospun nanofibers of chitosan/poly(vinyl alcohol). Water Sci Technol 77:1324–35.
  • Badran MM, Mady MM, Ghannam MM, et al. (2017). Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer. Int J Biol Macromol 95:643–9.
  • Dong H, Ma J, Wang J, et al. (2016). A biofunctional molecular beacon for detecting single base mutations in cancer cells. Mol Ther Nucleic Acids 5:e302.
  • Du Q, Li E, Liu Y, et al. (2018). CTAPIII/CXCL7: a novel biomarker for early diagnosis of lung cancer. Cancer Med 7:325–35.
  • DuPage M, Dooley AL, Jacks T. (2009). Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 4:1064–72.
  • Gabriel PM, Ignacimuthu S, Gandhi MR, et al. (2017). Comparative studies of tripolyphosphate and glutaraldehyde cross-linked chitosan-botanical pesticide nanoparticles and their agricultural applications. Int J Biol Macromol 104:1813–9.
  • Ganguly K, Kulkarni AR, Aminabhavi TM. (2015). In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-crosslinked chitosan microspheres in colorectal cancer therapy in rats. Drug Deliv 22:1–14.
  • Geng Y, Lin D, Shao L, et al. (2013). Cellular delivery of quantum dot-bound hybridization probe for detection of intracellular pre-microRNA using chitosan/poly(γ-glutamic acid) complex as a carrier. PLoS One 8:e65540.
  • Gür SD, İdil N, Aksöz N. (2018). Optimization of enzyme co-immobilization with sodium alginate and glutaraldehyde-activated chitosan beads. Appl Biochem Biotechnol 184:538–52.
  • Huang G, Liu Y, Chen L. (2017). Chitosan and its derivatives as vehicles for drug delivery. Drug Deliv 24:108–13.
  • Ju RJ, Cheng L, Peng XM, et al. (2018). Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer. Artif Cells Nanomed Biotechnol 30:1–13.
  • Kang WJ, Cho YL, Chae JR, et al. (2011). Molecular beacon-based bioimaging of multiple microRNAs during myogenesis. Biomaterials 32:1915–22.
  • Kharmate G, Rajput PS, Lin YC, et al. (2013). Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells. Cancer Cell Int 13:93.
  • Kim JK, Choi KJ, Lee M, et al. (2012). Molecular imaging of a cancer-targeting theragnostics probe using a nucleolin aptamer- and microRNA-221 molecular beacon-conjugated nanoparticle. Biomaterials 33:207–17.
  • Lapa C, Hänscheid H, Wild V, et al. (2016). Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy. Oncotarget 7:20033–40.
  • Lee J, Choi KJ, Moon SU, et al. (2016). Theragnosis-based combined cancer therapy using doxorubicin-conjugated microRNA-221 molecular beacon. Biomaterials 74:109–18.
  • Lee YJ, Moon SU, Park MG, et al. (2016). Multiplex bioimaging of piRNA molecular pathway-regulated theragnostic effects in a single breast cancer cell using a piRNA molecular beacon. Biomaterials 101:143–55.
  • Liu F, Song D, Wu Y, et al. (2017). MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer. Thorac Cancer 8:613–9.
  • Liu T, Jia T, Yuan X, et al. (2016). Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo. Int J Nanomedicine 23:2235–50.
  • Lu C, Xie Z, Peng Q. (2017). MiRNA-107 enhances chemosensitivity to paclitaxel by targeting antiapoptotic factor Bcl-w in non small cell lung cancer. Am J Cancer Res 7:1863–73.
  • Mikołajczak R, Maecke HR. (2016). Radiopharmaceuticals for somatostatin receptor imaging. Nucl Med Rev Cent East Eur 19:126–32.
  • Pan J, Song G, Chen D, et al. (2017). Identification of serological biomarkers for early diagnosis of lung cancer using a protein array-based approach. Mol Cell Proteomics 16:2069–78.
  • Raftery R, O'Brien FJ, Cryan SA. (2013). Chitosan for gene delivery and orthopedic tissue engineering applications. Molecules 18:5611–47.
  • Rocco G, Pennazza G, Santonico M, et al. (2018). Breathprinting and early diagnosis of lung cancer. J Thorac Oncol 18:30183–7.
  • Sato T, Nakata M, Yang Z, et al. (2017). In vitro and in vivo gene delivery using chitosan/hyaluronic acid nanoparticles: Influences of molecular mass of hyaluronic acid and lyophilization on transfection efficiency. J Gene Med 19:e2968. doi: 10.1002/jgm.2968.
  • Shahbaz M, Ruliang F, Xu Z, et al. (2015). mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer. World J Surg Oncol 13:46.
  • Shen Y, Zhang XY, Chen X, et al. (2017). Synthetic paclitaxel-octreotide conjugate reverses the resistance of paclitaxel in A2780/Taxol ovarian cancer cell line. Oncol Rep 37:219–26.
  • Sun ML, Wei JM, Wang XW, et al. (2007). Paclitaxel-octreotide conjugates inhibit growth of human non-small cell lung cancer cells in vitro. Exp Oncol 29:186–91.
  • Sun J, Yang L, Jiang M, et al. (2017). Stability and activity of immobilized trypsin on carboxymethyl chitosan-functionalized magnetic nanoparticles cross-linked with carbodiimide and glutaraldehyde. J Chromatogr B Analyt Technol Biomed Life Sci 1054:57–63.
  • Walker R, Deppen S, Smith G, et al. (2017). 68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer. PLoS One 12:e0171301.
  • Wang K, Chen M, Wu W. (2017). Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer. World J Surg Oncol 15:175.
  • Xie K, Ma H, Liang C, et al. (2015). A functional variant in miR-155 regulation region contributes to lung cancer risk and survival. Oncotarget 6:42781–92.
  • Xue X, Liu Y, Wang Y, et al. (2016). MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN. Oncotarget 7:84508–19.
  • Yu S, Zhang X, Tan G, et al. (2017). A novel pH-induced thermosensitive hydrogel composed of carboxymethyl chitosan and poloxamer cross-linked by glutaraldehyde for ophthalmic drug delivery. Carbohydr Polym 155:208–17.
  • Yuan Y, Zhang Q, Yan Y, et al. (2018). Designed construction of tween 60@2β-CD self-assembly vesicles as drug delivery carrier for cancer chemotherapy. Drug Deliv 25:623–31.
  • Zhang R, Gao S, Wang Z, et al. (2017). Multifunctional molecular beacon micelles for intracellular mRNA imaging and synergistic therapy in multidrug-resistant cancer cells. Adv Funct Mater 27:1701027.
  • Zhang Y, Sui J, Shen X, et al. (2017). Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Oncol Rep 37:3543–53.
  • Zhu HZ, An JH, Yao Q, et al. (2014). Chitosan combined with molecular beacon for mir-155 detection and imaging in lung cancer. Molecules 19:14710–22.